Announcements Trials
Browse Landscape

Phase

Phase NA 13Phase 3 2Phase 2 2Phase EARLY_PHASE1 1Phase 4 1Phase 1 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Periampullary Carcinoma Nos 1Neoplasms 1Enteritis 1Diarrhea 1Abdominal Pain 1

Interventions

Cyclophosphamide 297Cisplatin 297Paclitaxel 258Radiotherapy 253Fluorouracil 234Carboplatin 234Docetaxel 231Doxorubicin 212Dexamethasone 164Gemcitabine 155Vincristine 143Etoposide 133Leucovorin 132Capecitabine 129Bevacizumab 129Prednisone 124Rituximab 118Methotrexate 117Cytarabine 108Filgrastim 99Trastuzumab 98Oxaliplatin 96pembrolizumab 81Pemetrexed 73Epirubicin 70Tamoxifen 69Drug Therapy 69Irinotecan 65Granulocyte Colony-Stimulating Factor 60Nivolumab 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Completed × Probiotics × Clear all
NCT01468779 2017-03-03

Effect of Probiotics in Patients Undergoing Surgery for Periampullary Neoplasms

Hospital de Clinicas de Porto Alegre

Phase 3 Completed
58 enrolled

Periampullary Carcinoma Nos

NCT01839721 2013-05-17

Impact of Probiotics BIFILACT® on Diarrhea in Patients Treated With Pelvic Radiation

CHU de Quebec-Universite Laval

Phase 3 Completed
246 enrolled

Diarrhea, Enteritis, Neoplasms, Abdominal Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡